Athens Medical Centre (FRA:ACS) DeferredTaxAndRevenue: €0.0 Mil (As of Dec. 2025)


FRA:ACS Athens Medical Centre SA FRA:ACS
70 GF Score
Price €1.60
GF Value €1.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre DeferredTaxAndRevenue?

Athens Medical Centre FRA:ACS -0.31% 70 DeferredTaxAndRevenue is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:ACS with a GF Score™ of 70/100 and a GF Value™ of €1.72 (Fairly Valued). The stock has 8 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Athens Medical Centre's current deferred tax and revenue for the quarter that ended in Dec. 2025 was €0.0 Mil.

Athens Medical Centre DeferredTaxAndRevenue Related Terms

Athens Medical Centre DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre DeferredTaxAndRevenue Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:ACS
70GF Score
Athens Medical Centre SA FRA:ACS
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of €0.0 Mil mean?
Athens Medical Centre (FRA:ACS) has a DeferredTaxAndRevenue of €0.0 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Athens Medical Centre.
Is Athens Medical Centre's DeferredTaxAndRevenue too high?
Athens Medical Centre's current DeferredTaxAndRevenue is €0.0 Mil. Overall, Athens Medical Centre has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's DeferredTaxAndRevenue compare to HCA and THC?
Athens Medical Centre's DeferredTaxAndRevenue of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Athens Medical Centre. Athens Medical Centre's current DeferredTaxAndRevenue is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Fairly Valued. The stock's GF Value™ is €1.72, compared to a current price of €1.60 — trading 7.3% below its estimated fair value. The current DeferredTaxAndRevenue is €0.0 Mil. Athens Medical Centre's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current DeferredTaxAndRevenue is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.60 is trading 7.3% below its estimated GF Value™ of €1.72. GuruFocus considers Athens Medical Centre to be Fairly Valued.

Key valuation signals for FRA:ACS:

  • DeferredTaxAndRevenue: €0.0 Mil
  • GF Value™: €1.72 vs. price of €1.60 (7.3% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Other Exchanges IATR:Greece
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
70GF Score

Get the complete analysis for FRA:ACS

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.60
Price
€1.72
GF Value